The substantiation of scientific and methodical approaches to identification and evaluation of risks in parenteral medical forms combined production
DOI:
https://doi.org/10.24959/uekj.17.29Keywords:
cross contamination, identification of risks, formalized risk assessment algorithmAbstract
The article analyzes the scientific approaches to the assessment and minimization of the risks of cross contamination in the conditions of combined production, proposed an algorithm for the preliminary assessment of the risks of combined production of parenteral medical forms, developed an algorithm for a formalized assessment of the risks of cross contamination, the expert method substantiated the critical stages, the most significant factors and sources of risks of cross contamination of combined production of parenteral medical forms.
Aim. To identify the factors and sources of risk of co-production of parenteral medical forms, to develop algorithms for assessing the risks of joint production of parenteral medical forms and formalized assessment of the risks of cross contamination.
Materials and methods. Great attention was paid to preliminary assessment of the risks in combined production of parenteral medical forms; algorithm for a formalized assessment of the risks of cross contamination was taken into account; the expert method substantiated the critical stages.
Results. Eleven stages of assessing the risks of combined production of parenteral drugs, four critical stages, three most significant factors and four most significant sources of risk of cross contamination were identified.
Conclusions. The identified critical stages, factors, and sources of risk of cross contamination make it possible to identify benchmarks for assessing the risk of contamination of the combined production of parenteral medical forms.
References
Hoy, А. M., Voskoboinikova, H. L., Hapon, N. V. (2016). Fаrmаkоm, 2, 63–70.
Nastanova SТ–N МОZU 42–4.2:2011. Likarski zasoby. Upravlinnia ryzykamy dlia yakosti (ІСН Q9). (2011).
Кyiv: МОZ Ukrainy, 35.
Pomeshcheniia i zony farmatcevticheskogo predpriiatiia – proektirovanie, montazh, ekspluatatciia. (2010).
Farmatsevticheskaia otrasl, 1(18). Available at: http://archive.promoboz.com/n1_18/12–13.pdf
Spitskii, О. R. Provedenie analiza riskov pri proektirovanii i validatcii farmatcevticheskogo proizvodstva.
Available at: http://www.medbusiness.ru/440.php
Kostiuk, H. V. (2008). Vprovadzhennia pryntsypiv proektnoho menedzhmentu na farmatsevtychnykh pidpryiemstvakh
Ukrainy. Sohodennia ta maibutnie farmatsii. Kharkiv: NFаU, 535–536.
Lebedinets, V. A., Bursakov, A. V. (2008). Provisor, 17, 26–28.
Bart, J. (2010). 10 golden rules of project risk management. PROGECT SMART. Available at: https://www.
projectsmart.co.uk/10–golden–rules–of–project–risk–management.php
Lysenko, I. I. (2012). Farmatcevticheskaia otrasl, 1 (30), 92–93.
EMEA: White Paper, In Response to the EMEA’s Concept Paper. Dealing with the Need for Updated GMP
Guidance Concerning Dedicated Manufacturing Facilities in the Manufacture of Certain Medicinal Products.
Available at: http://ec.europa.eu/health/human–use/quality/developements/index_en.htm
Wilkins, S. (2008). Risk–MaPP: Manging the risk of cross contamination. Doc. Ref. EMEA/INS/GMP, 5,
Doc. № 14529.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
